Cenci Nilsson heads the Basal Ganglia Pathophysiology Laboratory at Lund University. Research activities in this laboratory aim at discovering mechanisms of symptom development in Parkinson's disease and other basal ganglia disorders. This knowledge is used to develop new symptomatic and disease-modifying treatments. In addition, the laboratory pursues the fundamental molecular and network-dysfunctions causing hypokinetic and hyperkinetic movement disorders.
Angela Cenci Nilsson (M. A. Cenci in all published papers) obtained a Medical Degree and a clinical specialization in Neurology at the University of Verona (Italy). This clinical education was followed by basic experimental studies at Lund University under the supervision of Prof. Anders Björklund, leading to a PhD degree in 1993. At Lund University, Cenci Nilsson received appointments as Assistant Professor (1993-2002), Lecturer (2002-2008), and Professor of Experimental Medical Science (from 2008).
Cenci Nilsson has pioneered the development of symptomatic models of parkinsonism and L-DOPA-induced dyskinesia in rodents, and has used these models to discover novel mechanisms of disease and new therapeutic approaches. For this research, Cenci Nilsson received the Erik K. Fernström Award for Young Promising Investigators (2003) and the Medal of Honours for Parkinson´s Research by the Swedish Parkinson’s Disease Foundation (2006).
Cenci Nilsson serves on the scientific advisory boards and steering committees of several national and international research organizations, including the Swedish Movement Disorder Society (from 2003); The Swedish Parkinson’s Disease Network (from 2009); The International Movement Disorders Society (from 2009), The M.J. Fox Foundation for Parkinson’s Research (from 2010); the International Brain Research Organisation (IBRO, from 2014); the Federation of European Neuroscience Societies (FENS) Committee for Higher Education and Research (from 2015).